Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
The current price of Beam (BEAM) is $0.0017758, as of Aug 28, 2026. Over the last 24 hours, the price has moved by 22.19%, with a change of 1.2% in the past hour. For longer-term performance, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results